By Counterforce Health Team in Tagrisso (osimertinib) —

How Long Does It Take to Get Tagrisso (Osimertinib) Approved by UnitedHealthcare in New Jersey? Complete Timeline Guide

Answer Box: Getting Tagrisso Approved by UnitedHealthcare in New Jersey

UnitedHealthcare's standard prior authorization for Tagrisso takes up to 15 business days, with expedited review in 72 hours for urgent cases. You need documented EGFR mutation testing and NSCLC diagnosis. If denied, you have 180 days to file an internal appeal, followed by New Jersey's Independent Health Care Appeals Program (IHCAP). Start by having your oncologist submit the PA through the UnitedHealthcare Provider Portal with complete EGFR mutation test results and pathology reports.

Table of Contents

  1. What Affects Tagrisso Approval Timing
  2. Pre-Submission Preparation (0-2 Days)
  3. Initial Review Process (1-15 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window & Outcomes
  6. If Denied: New Jersey Appeal Timeline
  7. Renewal Cycles & Reauthorization
  8. Timeline Visual & Milestones
  9. Time-Saving Tips
  10. Common Denial Reasons & Solutions
  11. Cost Information
  12. FAQ

What Affects Tagrisso Approval Timing

Several factors influence how quickly UnitedHealthcare approves Tagrisso (osimertinib) in New Jersey:

Documentation Completeness: The most critical factor is having complete EGFR mutation testing results. UnitedHealthcare requires specific mutation documentation (exon 19 deletion, L858R, or T790M mutations) using FDA-approved testing methods.

Benefit Type: Commercial plans typically process faster than Medicare Advantage plans, which may require additional documentation for medical necessity determinations.

Clinical Complexity: First-line metastatic NSCLC cases with clear EGFR mutations process faster than adjuvant settings or cases requiring step therapy exceptions.

Pre-Submission Preparation (0-2 Days)

Before your oncologist submits the prior authorization, gather these essential documents:

Required Documentation Checklist

  • EGFR Mutation Test Results: Lab report showing specific mutation type from FDA-approved assay
  • Pathology Report: Complete report confirming NSCLC diagnosis with ICD-10 codes
  • Current Imaging: Disease staging (metastatic, locally advanced, or adjuvant setting)
  • Treatment History: Prior therapies attempted, failures, or documented contraindications
  • Insurance Information: Member ID, group number, and plan details
Tip: Request expedited EGFR testing if results are pending. Most labs can provide preliminary results within 24-48 hours for urgent oncology cases.

Initial Review Process (1-15 Days)

UnitedHealthcare's standard prior authorization timeline is up to 15 business days from submission. Here's what happens during review:

Standard Review Timeline

  • Days 1-3: Administrative review for completeness
  • Days 4-10: Clinical review by oncology specialists
  • Days 11-15: Final determination and notification

Expedited Review (72 Hours)

Available when delay could seriously jeopardize patient health. Your oncologist should:

  • Document disease progression or aggressive cancer behavior
  • Include imaging showing rapid progression
  • Request 72-hour expedited review in the submission

Submit through the UnitedHealthcare Provider Portal under "Prior Authorization & Notifications."

Additional Information Requests (1-7 Days)

If UnitedHealthcare requests additional information, respond within 5 business days to avoid delays:

Common Requests:

  • More detailed EGFR mutation testing methodology
  • Complete staging workup or imaging reports
  • Documentation of contraindications to alternative EGFR TKIs
  • Peer-to-peer review with the medical director
Note: Use the same portal submission method for additional documentation. Include the original reference number from your initial submission.

Decision Window & Outcomes

UnitedHealthcare will issue one of three decisions:

Decision Type Timeline Next Steps
Approved Within 15 days Authorization valid for 12 months; use OptumRx Specialty Pharmacy
Denied Within 15 days 180 days to file internal appeal in New Jersey
Pending After 15 days Contact UnitedHealthcare at 877-842-3210 with reference number

Initial authorizations are typically granted for 12 months with automatic refill authorization based on continued medical necessity.

If Denied: New Jersey Appeal Timeline

New Jersey provides robust appeal rights with specific timelines:

Internal Appeals (Two Levels Required)

Level 1 Internal Appeal

  • Filing Deadline: 180 days from denial date
  • Decision Timeline: 30 calendar days (72 hours if expedited)
  • Submission: Provider portal, mail, or fax to UnitedHealthcare

Level 2 Internal Appeal

  • Trigger: Only if Level 1 is denied
  • Same Timeline: 180-day filing window applies
  • Peer-to-Peer Option: Available by calling 888-397-8129

External Review Through IHCAP

After completing both internal appeal levels, New Jersey residents can access the Independent Health Care Appeals Program (IHCAP) administered by Maximus:

  • Filing Deadline: 4 months from final internal denial
  • Review Timeline: 45 days for standard appeals
  • Cost: No patient cost—insurers pay all review fees
  • Success Rate: Approximately 50% of external appeals favor consumers

Contact IHCAP at 1-888-393-1062 or the New Jersey Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Renewal Cycles & Reauthorization

Tagrisso reauthorization is typically required every 12 months. To ensure continuity:

60 Days Before Expiration:

  • Schedule oncology follow-up with imaging
  • Document treatment response and tolerability
  • Submit reauthorization request

Reauthorization Requirements:

  • Continued NSCLC diagnosis
  • Documented clinical benefit (stable disease or response)
  • No prohibitive toxicities requiring discontinuation

Timeline Visual & Milestones

Milestone Standard Timeline Expedited Timeline Key Actions
Pre-Submission 0-2 days Same Gather EGFR results, pathology
Initial Submission Day 0 Day 0 Submit via provider portal
Administrative Review Days 1-3 Hours 1-12 Completeness check
Clinical Review Days 4-14 Hours 13-72 Oncology specialist review
Decision Issued Day 15 Hour 72 Approval/denial notification
Internal Appeal (if denied) 180 days to file Same Two-level process required
External Review 4 months to file Same IHCAP through Maximus

Time-Saving Tips

Portal Optimization: Use the UnitedHealthcare Provider Portal's "Prior Authorization & Notifications" tool for real-time status tracking and faster processing.

Bundled Evidence: Submit all required documentation in the initial request rather than waiting for additional information requests.

Direct Specialty Routing: Ensure submissions are routed to oncology specialists by clearly indicating "EGFR+ NSCLC" in the clinical summary.

Template Letters: Develop standardized medical necessity letter templates that address UnitedHealthcare's specific coverage criteria for Tagrisso.

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
Missing EGFR mutation Resubmit with complete testing FDA-approved assay results
Insufficient staging Add imaging reports CT chest/abdomen/pelvis with staging
Step therapy required Document contraindications Medical records showing intolerance
Non-formulary status Request formulary exception Clinical guidelines supporting use

Cost Information

Once approved, Tagrisso typically has $0 copay for covered UnitedHealthcare members under current regulations. The medication must be dispensed through OptumRx Specialty Pharmacy.

Additional Cost Support:

Counterforce Health helps patients and clinicians navigate complex prior authorization processes like Tagrisso approvals. Our platform analyzes denial letters, identifies specific coverage criteria, and generates evidence-backed appeals that align with payer policies. By understanding exactly what UnitedHealthcare requires for Tagrisso approval—from EGFR mutation documentation to medical necessity justification—we help turn denials into approvals.

For complex cases requiring multiple appeals or external review, Counterforce Health provides specialized support for oncology drug approvals, including detailed analysis of UnitedHealthcare's specific coverage policies and appeal strategies tailored to New Jersey's regulatory environment.

FAQ

How long does UnitedHealthcare prior authorization take for Tagrisso in New Jersey? Standard processing takes up to 15 business days, with expedited review available in 72 hours for urgent cases.

What EGFR mutations qualify for Tagrisso coverage? UnitedHealthcare covers Tagrisso for NSCLC with exon 19 deletions, L858R mutations, or T790M mutations confirmed by FDA-approved testing.

Can I request an expedited appeal in New Jersey? Yes, expedited appeals are available when delay could seriously jeopardize patient health, with 72-hour decision timelines.

Does step therapy apply to Tagrisso? UnitedHealthcare may require trials of lower-cost EGFR TKIs first, but exceptions are available with documented contraindications or treatment failures.

What happens if both internal appeals are denied? New Jersey residents can file for external review through IHCAP within 4 months of the final internal denial, with no cost to the patient.

How often does Tagrisso require reauthorization? Initial authorizations are valid for 12 months, with reauthorization required based on continued medical necessity and treatment response.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan benefits and medical circumstances. Always consult with your healthcare provider and insurance plan for specific coverage determinations. For assistance with New Jersey insurance appeals, contact the Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.